Shypd.aiThe largest open index of AI toolsImpriMed is a Clinical & Healthcare Pro tool that uses AI-driven precision medicine to predict drug responses for oncology. It offers specialized services for veterinary and human blood cancers, as well as CRO services for pharmaceutical companies.
Trending
About
ImpriMed, Inc. is a pioneering company in AI-driven precision medicine, focusing on oncology. They leverage live-cell testing and artificial intelligence to predict drug responses, aiming to connect the right drug to the right patient. Their services extend to veterinary precision medicine, helping oncologists find optimal treatments for canine and feline blood cancers. Additionally, ImpriMed offers human precision medicine for predicting patient-specific drug responses (for research and investigational use only) and provides Ex Vivo CRO services to pharmaceutical companies to accelerate oncology drug development pipelines with live-cell-based analytics. The company is based in Palo Alto, CA, and Seoul, with services available in the US, Canada, England, France, and South Korea.
Capabilities
Pricing & Plans
Paid
Not publicly disclosed. Check imprimedicine.com for current pricing.
FAQs
Trending
